期刊文献+

天舒胶囊联合养血清脑颗粒治疗偏头痛疗效观察 被引量:5

Clinical effect observation of Tianshu capsule and Yangxue Qingnao Keli in the treatment of migraine
下载PDF
导出
摘要 目的观察天舒胶囊联合养血清脑颗粒治疗偏头痛的疗效,并探讨其作用机制。方法将80例偏头痛患者随机分组为治疗组(40例)和对照组(40例)。治疗组采用天舒胶囊,每天3次,每次4粒(共1.36g),养血清脑颗粒每天3次,每次1包(3g)口服治疗,连续治疗2个月。对照组采用盐酸氟桂利嗪5~10mg,每晚口服1次,连续治疗2个月。观察期间不得服用其他镇痛剂。记录偏头痛发作频率和每月头痛发作持续时间。治疗前和治疗2个月时进行肝、肾功能,血、尿常规,心电图和TCD检查。随访半年。结果天舒胶囊联合养血清脑颗粒可减少偏头痛的发作频率,缩短每月头痛发作持续时间。结论天舒胶囊联合养血清脑颗粒能够减少偏头痛的发作频率和严重程度,具有更持久的预防保护作用,副作用小。 Objective To explore the clinical effect and mechanism of Tianshu capsule and Yangxue Qingnao Keli on migarine.Methods Eighty cases of patients with migraine were randomly divided into the treatment group(40 cases),which were treated with oral Tianshu capsule,4 capsules(1.36 g),3 times daily,Yangxue Qingnao Keli 1 bag(3 g),3 times daily,and the control group(40 cases),which were treated with Flunarizine 5-10 mg,quaquenocte for 2 months.Six months follow-up was carried out.The frequency and duration of migraine were analyzed before and after treatment.The liver and kidney function,blood and urine routine,electrocardiograph as well as TCD were compared before and after treatment.Results In the treatment group the frequency and duration of migraine decreased more than those of control group.Conclusion Tianshu capsule and Yangxue Qingnao Keli can ameliorate the migraine frequency and as well as the severity than that of Flunarizine,and has longer prevention effect on migraine without extrapyramidal system responses.
作者 程武
出处 《中国当代医药》 2012年第24期114-115,共2页 China Modern Medicine
关键词 天舒胶囊 养血清脑颗粒 偏头痛 疗效 Tianshu capsule Yangxue Qingnao Keli Migraine Effect
  • 相关文献

参考文献6

二级参考文献7

共引文献84

同被引文献32

  • 1张勤,杨天华,周沐科,周东.天舒胶囊对偏头痛动物模型血浆一氧化氮、一氧化氮合酶、降钙素基因相关肽含量及血流动力学的影响[J].临床神经病学杂志,2008,21(4):279-282. 被引量:26
  • 2王忠诚 程学铭 等.中国六城市居民神经系统疾病的流行病学调查[J].中华神经外科杂志,1985,1:2-4. 被引量:35
  • 3石学敏,唐玉秀,周行晓.针灸治疗学[M].上海:上海科学技术出版社,2002. 被引量:17
  • 4中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119. 被引量:985
  • 5WHO. The Global Burden of Disease, 2004 update [ J ] Geneva, Switzerland: World Health Organization, 2004. 被引量:1
  • 6WHO. The Global Burden of Disease, 2004 update [ J] Geneva, Switzerland: World Health Organization, 2004. 被引量:1
  • 7Antonaci F, Dumit rache C, De Cillis I, et al. A review of current European treatment guidelines for migraine [J]. J Headache Pain, 2010,11 (1) :13-19. 被引量:1
  • 8Silberstein S D. Practice parameter: evidence based guide- lines for migraine headache ( an evidence based review) : report of the Quality Standards Subcommittee of the Ameri- can Academy of Neurology [ J ]. Neurology, 2000,55 ( 6 ) : 754 -762. 被引量:1
  • 9Silberstein S D, Lipton R B. Overview of diagnosis and treatment of migraine [ J ]. Neurology, 1994,44 ( 10 Suppl 7 ) : $6-S16. 被引量:1
  • 10Zhao J G, Cao C H, Liu C Z, et al. Effect of acupunc- ture treatment on spastic states of stroke patients [ J 1. J Neurol Sei, 2009,276 ( 1-2 ) : 143-147. 被引量:1

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部